Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Zavesca
Miglustat
Actelion
Main Therapeutic Indication : Rare Diseases
Currency : USD
2016 Revenue in Millions : 103
2015 Revenue in Millions : 91
Growth (%) : 13
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF